[
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "<10^−4",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "0.001",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "0.005",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "0.01",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "0.05",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "0.1",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "0.5",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "1",
        "unit": "nM",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−5",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−6",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−7",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−8",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−9",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−10",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−11",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−12",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−13",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−14",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "CLL-1",
        "binding_metric": "Kd",
        "value": "10^−15",
        "unit": "M",
        "raw_mentions": "In certain embodiments, an antibody described herein exhibits high affinity for binding an antigen (e.g., CLL-1) with a K<sub>D </sub>of less than about 10<sup>−4</sup>, 10<sup>−5</sup>, 10<sup>−6</sup>, 10<sup>−7</sup>, 10<sup>−8</sup>, 10<sup>−9</sup>, 10<sup>−10</sup>, 10<sup>−11</sup>, 10<sup>−12</sup>, 10<sup>−13</sup>, 10<sup>−14</sup>, or 10<sup>−15</sup>M.\nIn certain instances, K<sub>D </sub>of an antibody as described herein for an antigen (e.g., CLL-1) is between 0.001 and 1 nM, e.g., 0.001 nM, 0.005 nM, 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, or 1 nM."
    },
    {
        "molecule_name": "Leu16scFv-CD19",
        "protein_target_name": "CD19",
        "binding_metric": "Kd",
        "value": "˜3",
        "unit": "nm",
        "raw_mentions": "The Leu16scFv-CD19 construct had a Kd of ˜3 nm whereas the Rituximab-based construct, i.e. the full Rituximab mAb, had a Kd of ˜16 pM."
    },
    {
        "molecule_name": "Rituximab",
        "protein_target_name": "CD19",
        "binding_metric": "Kd",
        "value": "˜16",
        "unit": "pM",
        "raw_mentions": "The Leu16scFv-CD19 construct had a Kd of ˜3 nm whereas the Rituximab-based construct, i.e. the full Rituximab mAb, had a Kd of ˜16 pM."
    }
]